Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bitterman

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Harefuah|February 20, 2002
[The European Federation of Internal Medicine in Edinburgh 9-12 May, 2001]H Bitterman
Harefuah|January 1, 1985
[Retroperitoneal lymphadenopathy in cat scratch syndrome]H Bitterman, L Cohen
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 6, 1998
L-arginine-NO pathway and CNS oxygen toxicityN Bitterman, H Bitterman
Israel Journal of Medical Sciences|January 1, 1993
Delayed hyperbaric treatment of cerebral air embolismH Bitterman, Y Melamed
Physiological Measurement|July 22, 2008
ECG variability contour--a reference for evaluating the significance of amplitude ECG changes in two statesG Dori, H Bitterman
Harefuah|March 15, 1987
[Oxygen toxicity]N Bitterman, H Bitterman
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1988
Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shockH Bitterman, A M Lefer
Harefuah|April 1, 1983
[Hypertensive encephalopathy]H Bitterman, D Rimon, L Cohen
Clinical Nuclear Medicine|November 1, 1994
Scintigraphic evaluation of a patient with lung cavitations. Ga-67 scintigraphy is nondiagnosticD Zisman, R Hardoff, H Bitterman
Harefuah|April 15, 1996
[Cholesterol emboli]G Weisz, M Ciobotaru, H Bitterman
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Harefuah|February 20, 2002
[The European Federation of Internal Medicine in Edinburgh 9-12 May, 2001]H Bitterman
Harefuah|January 1, 1985
[Retroperitoneal lymphadenopathy in cat scratch syndrome]H Bitterman, L Cohen
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 6, 1998
L-arginine-NO pathway and CNS oxygen toxicityN Bitterman, H Bitterman
Israel Journal of Medical Sciences|January 1, 1993
Delayed hyperbaric treatment of cerebral air embolismH Bitterman, Y Melamed
Physiological Measurement|July 22, 2008
ECG variability contour--a reference for evaluating the significance of amplitude ECG changes in two statesG Dori, H Bitterman
Harefuah|March 15, 1987
[Oxygen toxicity]N Bitterman, H Bitterman
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1988
Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shockH Bitterman, A M Lefer
Harefuah|April 1, 1983
[Hypertensive encephalopathy]H Bitterman, D Rimon, L Cohen
Clinical Nuclear Medicine|November 1, 1994
Scintigraphic evaluation of a patient with lung cavitations. Ga-67 scintigraphy is nondiagnosticD Zisman, R Hardoff, H Bitterman
Harefuah|April 15, 1996
[Cholesterol emboli]G Weisz, M Ciobotaru, H Bitterman
Pageof 7